CLEVER LEAVES HLDGS WTS (CLVRW) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 0 8 sessions, September 10, 2025 to December 12, 2025
- Largest daily move
- +0% close of September 16, 2025
Company Description
CLEVER LEAVES HLDGS WTS (OTC: CLVRW) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector.
CLVRW has gained 0.0% over the past week. The last closing price was $0.0001.
This page collects what Stock Titan holds for CLVRW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CLEVER LEAVES HLDGS WTS (CLVRW) closed at $0.0001 on December 12, 2025. Over the past week, the price has gained 0.0%.
CLVRW Metrics & Rankings
Price returns through December 12, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CLEVER LEAVES HLDGS WTS has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 7 with negative movement. Key topics include earnings, conferences, stock split. View all CLVRW news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in CLEVER LEAVES HLDGS WTS (CLVRW) currently stands at 1.7 thousand shares, representing 0.1% of the shares outstanding.
Days to Cover History
Days to cover for CLEVER LEAVES HLDGS WTS (CLVRW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
CLVRW Company Profile & Sector Positioning
CLEVER LEAVES HLDGS WTS (CLVRW) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CLVRW often look at related companies in the same sector, including Biofrontera Inc. Warrants (BFRIW), IM Cannabis Corp. (IMCC), China Pharma Holdings, Inc. (CPHI), Sunshine Biopharma Inc. warrant (SBFMW), and Flora Growth Corp. (FLGC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLVRW's relative position within its industry.